A0A2K5KSK4 (A0A2K5KSK4_CERAT) Cercocebus atys (Sooty mangabey) (Cercocebus torquatus atys)
Hypoxia inducible factor 1 subunit alpha inhibitor UniProtKBInterProSTRINGInteractive Modelling
349 aa; Sequence (Fasta) ;
9 identical sequences: Homo sapiens: Q9NWT6; Mandrillus leucophaeus: A0A2K6AAA4; Theropithecus gelada: A0A8D2K4B2; Macaca mulatta: H9ZB15, A0A8J8XH10; Macaca fascicularis: G7PDR7; Chlorocebus sabaeus: A0A0D9QZU0; Piliocolobus tephrosceles: A0A8C9I1L9; Colobus angolensis palliatus: A0A2K5IL80
It is possible new templates exist for this target since these models were created.
Available Structures
59 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPA1 (313-339) |
Heteromer O75762; Q9NWT6; | 100.0 | 2×ZN; 2×OGA; 2×SO4; 6×GOL; | |||
| FACTOR INHIBITING HIF (FIH) Q239H MUTANT IN COMPLEX WITH ZN(II), NOG AND ASP-SUBSTRATE PEPTIDE (20-… |
Heteromer Q9NWT6; | 99.71 | 2×ZN; 2×OGA; 6×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-LEU PEPTIDE (20-MER) |
Heteromer Q9NWT6; | 100 | 2×ZN; 2×OGA; 10×SO4; 8×GOL; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 4-ethyl-2-oxoglutarate, AND CONSENSUS ANKYRIN… |
Heteromer Q9NWT6; | 100 | 2×ZN; 8×SO4; 2×QVT; | |||
| Crystal structure of human FIH D201E variant in complex with Zn, alpha-ketoglutarate, and HIF1 alph… |
Heteromer Q16665; Q9NWT6; | 99.71 | 2×AKG; 2×GOL; 2×ZN; 8×SO4; | |||
| Factor Inhibiting HIF-1 Alpha D201A Mutant in Complex with FE(II), Alpha-Ketoglutarate and HIF-1 Al… |
Heteromer Q16665; Q9NWT6; | 99.71 | 2×FE2; 4×SO4; 2×BCT; 2×AKG; 6×GOL; | |||
| Factor inhibiting HIF-1 Alpha in complex with Notch 1 fragment mouse notch (1930-1949) peptide |
Heteromer Q01705; Q9NWT6; | 100 | 2×FE2; 4×SO4; 2×AKG; 8×GOL; | |||
| Factor inhibiting HIF-1 Alpha in complex with Notch 1 fragment mouse notch (1997-2016) peptide |
Heteromer Q01705; Q9NWT6; | 100 | 2×FE2; 2×AKG; 4×SO4; 6×GOL; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPV3 (220-246) |
Heteromer Q8NET8; Q9NWT6; | 100 | 2×OGA; 8×SO4; 6×GOL; 2×ZN; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH TANKYRASE-2 (TNKS2) FRAGMENT PEPTIDE (21-MER) |
Heteromer Q9H2K2; Q9NWT6; | 100 | 2×FE2; 2×AKG; 6×SO4; 4×GOL; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-(carboxycarbonyl)cyclopentane-1-carboxylic … |
Heteromer Q9NWT6; | 100 | 2×ZN; 6×SO4; 2×QVQ; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 4-propyl-2-oxoglutarate, AND CONSENSUS ANKYRI… |
Heteromer Q9NWT6; | 100 | 2×ZN; 6×SO4; 2×QW2; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc, NOG and TRPV3 (229-255) |
Heteromer Q8NET8; Q9NWT6; | 100 | 2×OGA; 6×GOL; 8×SO4; 2×ZN; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc, NOG and ASPP2 (970-992) |
Heteromer Q13625; Q9NWT6; | 100 | 12×SO4; 10×GOL; 2×OGA; 2×ZN; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc, NOG and ASPP1(932-954) |
Heteromer Q96KQ4; Q9NWT6; | 100 | 8×GOL; 8×SO4; 2×ZN; 2×OGA; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc, NOG and iASPP(670-693) |
Heteromer Q8WUF5; Q9NWT6; | 100 | 10×GOL; 6×SO4; 2×ZN; 2×OGA; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-methyl-2-oxoglutarate, AND TANKYRASE-2 (TNK… |
Heteromer Q9H2K2; Q9NWT6; | 100 | 8×SO4; 1×ROQ; 1×ZN; | |||
| Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide |
Heteromer Q16665; Q9NWT6; | 100.0 | 2×FE2; 2×OGA; 4×SO4; | |||
| Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide |
Heteromer Q16665; Q9NWT6; | 100.0 | 2×FE2; 2×AKG; 4×SO4; | |||
| Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide |
Heteromer Q16665; Q9NWT6; | 100.0 | 2×ZN; 2×OGA; 4×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 3-methyl-2-oxoglutarate, AND CONSENSUS ANKYRI… |
Heteromer Q9NWT6; | 100 | 9×SO4; 1×ZN; 1×ROQ; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH R-2-HYDROXYGLUTARATE | homo-2-mer | 100 | 2×FE2; 2×2HG; 6×GOL; 8×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH S-2-HYDROXYGLUTARATE | homo-2-mer | 100 | 2×FE; 4×S2G; 4×GOL; 8×SO4; | |||
| Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)3-hydroxy-Leu pept… | homo-2-mer | 100 | 2×ZN; 2×OGA; 6×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA WITH PYRIDINE 2,4 DICARBOXYLIC ACID | homo-2-mer | 100 | 2×FE2; 2×PD2; 6×SO4; 2×GOL; | |||
| Crystal Structure of Factor Inhibiting HIF-1 Alpha Complexed with Inhibitor | homo-2-mer | 100 | 2×ZN; 2×8XQ; 6×SO4; 8×GOL; | |||
| Structure of Factor Inhibiting HIF (FIH) in complex with Fe, NO, and NOG | homo-2-mer | 100 | 2×OGA; 2×NO; 2×PEG; 2×FE; 10×SO4; | |||
| Factor Inhibiting HIF D201E in Complex with Fe, and Alpha-Ketoglutarate | homo-2-mer | 99.71 | 2×AKG; 2×PEG; 2×FE2; 4×SO4; | |||
| Factor Inhibiting HIF D201E in Complex with Zn, and Alpha-Ketoglutarate | homo-2-mer | 99.71 | 2×AKG; 2×PEG; 2×ZN; 4×SO4; | |||
| Factor Inhibiting HIF in Complex with Fe, and Alpha-Ketoglutarate | homo-2-mer | 100 | 2×AKG; 2×PEG; 2×FE; 10×SO4; | |||
| Factor inhibiting HIF-1 alpha D201G mutant in complex with ZN(II), alpha-ketoglutarate and HIF-1 al… | homo-2-mer | 99.7 | 2×ZN; 4×SO4; 2×AKG; 2×GOL; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc and Vadadustat | homo-2-mer | 100 | 10×SO4; 2×ZN; 10×GOL; 2×A1Z; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH DAMINOZIDE | homo-2-mer | 100 | 10×SO4; 6×GOL; 2×DZA; 2×ZN; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH 8-HYDROXYQUINOLINE-5- CARBOXYLIC ACID | homo-2-mer | 100 | 2×FE; 2×8XQ; 10×SO4; 8×GOL; | |||
| Factor-inhibiting hypoxia-inducible factor in complex with Zn(II) and 2-(3-hydroxy-2-((1-(phenylsul… | homo-2-mer | 100 | 14×SO4; 14×GOL; 2×ZN; 2×VK6; | |||
| Factor-inhibiting hypoxia-inducible factor in complex with Zn(II) and 2-(3-hydroxy-2-((2-((naphthal… | homo-2-mer | 100 | 2×ZN; 2×VIZ; 16×SO4; 14×GOL; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-SER PEPTIDE (20-MER) | homo-2-mer | 100 | 2×ZN; 2×OGA; 8×SO4; | |||
| Factor-inhibiting hypoxia-inducible factor in complex with Zn(II) and 2-(3-hydroxy-2-((3-(phenylsul… | homo-2-mer | 100 | 20×SO4; 6×GOL; 2×ZN; 2×VJF; | |||
| Dimeric structure of FIH (Factor inhibiting HIF) | homo-2-mer | 99.7 | 2×SO4; | |||
| Human Factor Inhibiting HIF (FIH1) | homo-2-mer | 100.0 | 2×FE2; 2×TAR; | |||
| Human Factor inhibiting HIF (FIH1) in Complex with 2-oxoglutarate | homo-2-mer | 100.0 | 2×FE2; 2×AKG; | |||
| Factor inhibiting HIF-1 alpha in complex with N-(carboxycarbonyl)-D-phenylalanine | homo-2-mer | 100 | 2×FE2; 6×SO4; 4×NDF; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-(3-phenylpropyl)-2-oxoglutarate | homo-2-mer | 100 | 2×ZN; 10×SO4; 2×QVN; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-((9,9-dimethyl-9H-fluoren-2-yl)methyl)-2… | homo-2-mer | 100 | 2×ZN; 2×QVZ; 8×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-propyl-2-oxoglutarate | homo-2-mer | 100 | 2×ZN; 2×QVW; 6×SO4; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc and Molidustat | homo-2-mer | 100 | 2×ZN; 2×A1H; 6×SO4; 4×GOL; | |||
| FACTOR INHIBITING HIF-1 ALPHA WITH 2-(3-hydroxyphenyl)-2-oxoacetic acid | homo-2-mer | 100 | 2×FE2; 2×A29; | |||
| FACTOR INHIBITING HIF-1 ALPHA WITH N,3-dihydroxybenzamide | homo-2-mer | 100.0 | 2×FE2; 4×069; 2×SO4; | |||
| Factor inhibiting HIF-1 alpha in complex with 8-hydroxyquinoline | homo-2-mer | 100.0 | 2×FE2; 4×SO4; 2×HQY; | |||
| Factor inhibiting HIF-1 alpha in complex with Clioquinol | homo-2-mer | 100.0 | 2×FE2; 4×SO4; 6×GOL; 2×CQL; | |||
| Factor Inhibiting HIF-1 alpha | homo-2-mer | 100.0 | 2×FE2; 2×AKG; 6×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA with succinate | monomer | 100.0 | 1×FE; 1×SIN; 4×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA with fumarate | monomer | 100.0 | 1×FE; 1×FUM; 4×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA in complex with (5-(3-(3-chlorophenyl)isoxazol-5-yl)-3-hydroxypicolin… | monomer | 100 | 1×P5I; 2×GOL; 1×ZN; 8×SO4; | |||
| FACTOR INHIBITING HIF-1 ALPHA in complex with (5-(1-(3-(4-chlorophenyl)propyl)-1H-1,2,3-triazol-4-y… | monomer | 100 | 14×SO4; 1×ZN; 1×P1X; | |||
| FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-methyl-2-oxoglutarate | monomer | 100 | 1×ROQ; 1×ZN; 4×SO4; | |||
| Factor Inhibiting HIF (FIH) in complex with zinc and GSK128863 | monomer | 100.0 | 1×ZN; 2×SO4; 1×A0W; 1×GOL; | |||
| Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)allyl-GLY peptide | monomer | 100 | 1×ZN; 1×OGA; 3×SO4; | |||
| Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)LEU peptide | monomer | 100 | 1×ZN; 1×OGA; 2×SO4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5jwk.1.B | homo-2-mer | 0.91 | 99.71 | |||